pantothenic acid has been researched along with Clerambault Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krasnoslobodtseva, LA; Lapin, IA; Mel'nikova, TS; Nazmetdinova, DM; Rogacheva, TA | 1 |
| Avrutskiĭ, GIa; Laskova, NB | 1 |
2 other study(ies) available for pantothenic acid and Clerambault Syndrome
| Article | Year |
|---|---|
[Pantogam in the treatment of patients with organic brain lesions of different genesis].
Topics: Adult; Electroencephalography; Female; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Neurocognitive Disorders; Nootropic Agents; Pantothenic Acid; Treatment Outcome | 2010 |
[Certain principles for differential utilization of metabolic treatment preparations in the complex therapy of mental disorders].
Topics: Adolescent; Adult; Aged; Bipolar Disorder; Brain Injuries; gamma-Aminobutyric Acid; Humans; Infections; Mental Disorders; Middle Aged; Neurocognitive Disorders; Pantothenic Acid; Piracetam; Pyridines; Pyrithioxin; Pyrrolidinones; Schizophrenia; Skull | 1979 |